We are able to price our services below other contract research organizations (CROs) because we conduct studies in leading research centers located in Eastern Europe, where labor and other costs are lower than in the U.S. or Western Europe. This is an exceptional value for early-stage companies with limited cash that need to demonstrate pre-clinical program results in order to attract investors or otherwise obtain funding. We provide companies with a means to show preliminary efficacy and safety through in vitro and animal studies.